Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-04-15

Clinical Trial Update: Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Osteoarthritic Pain [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Buprenorphine Transdermal System (BTDS) versus placebo in osteoarthritis-related pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPRENORPHINE TRANSDERMAL SYSTEM (buprenorphine)

Snippet

Sponsor: Mundipharma K.K. | Conditions: Pain, Osteoarthritis | Phase 3 | Status: COMPLETED